FIELD: pharmacology.
SUBSTANCE: drug in the form of easily soluble biocompatible film for transbuccal application includes a therapeutically effective amount of pharmacologically active agent, such as a salt of alkaline or alkaline-earth metal 5-amino-2.3-dihydrophthalazine-1.4-dione as a waterless salt or its monohydrate or dihydrate, or their mixtures, mucoadhesive film forming polymer plasticiser and taste flavour, represented by a mixture of β-cyclodextrin or modified β-cyclodextrin with sorbitol when their mass ratio of 4:1-1:2, the content of the specified mixture in the film is 15-40 wt % of the weight of the entire film.
EFFECT: increased release speed of the pharmacologically active agent when applying the film, increased transparency, uniformity and stability in storage while retaining elasticity and strength.
16 cl, 5 tbl
Title | Year | Author | Number |
---|---|---|---|
METHOD FOR PRODUCING A MEDICINAL PRODUCT | 2020 |
|
RU2774597C1 |
METHOD FOR PRODUCING A MEDICINAL PRODUCT | 2020 |
|
RU2774615C1 |
METHOD FOR MANUFACTURE OF NON-STERILE SUBSTANCES OF NON-AQUEOUS "TAMERIT" AND/OR DOUBLE-AQUEOUS "GALAVIT" - SODIUM SALTS OF 5-AMINO-2,3-DIHYDROPHTHALAZINE-1,4-DIONE (VERSIONS) AND METHODS FOR FURTHER PROCESSING THEREOF TO OBTAIN STERILE MEDICINAL PREPARATIONS | 2016 |
|
RU2625267C1 |
SODIUM AMINODIHYDROPHTHALAZINEDIONE SOLUTION FOR INTRAVENOUS ADMINISTRATION | 2023 |
|
RU2821033C1 |
METHOD OF DRUG PRODUCING | 2000 |
|
RU2155043C1 |
BIODEGRADABLE SYSTEM OF TRANSMUCOSAL DELIVERY OF DROTAVERIN | 2017 |
|
RU2699808C2 |
MEDICINAL AGENT | 2000 |
|
RU2163122C1 |
DOSAGE FORM FOR RELEASING DROTAVERINE IN ORAL CAVITY | 2019 |
|
RU2729659C1 |
MEDICINAL PREPARATION (VARIANTS) | 2003 |
|
RU2302863C2 |
LAMINAR DRUG DELIVERY DEVICE | 2011 |
|
RU2594064C2 |
Authors
Dates
2017-11-15—Published
2017-02-08—Filed